beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Term ID

CHEBI:68442

Synonyms

2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-DGal-(1->4)-beta-D-GlcNAc
beta-D-glucopyranose, O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->3)-O-alpha-D-galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-
GalNAcb1-3Gala1-4Galb1-4GlcNAcb
GalNAcbeta1-3Galalpha1-4Galbeta1-4GlcNAcbeta
N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
O-2-(acetylamino)-2-deoxy-beta-D-galactopyranosyl-(1->3)-O-alpha-D-galactopyranosyl-(1->4)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose

Definition

A linear amino tetrasaccharide composed of N-acetyl-β-D-galactosamine, α-D-galactose, β-D-galactose and N-acetyl-β-D-galactosamine units joined by sequential (1→3)-, (1→4)- and (1→4)-linkages.

References

glygen:G29548YX
glytoucan:G29548YX
pubmed:19443021
pubmed:25568069
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype where environments contain beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype modified by environments containing beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Phenotype affecting beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc

Human Disease Model